Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enveric Biosciences

1.35
-0.0300-2.17%
Post-market: 1.370.0199+1.47%17:17 EDT
Volume:34.36K
Turnover:46.24K
Market Cap:3.34M
PE:-0.07
High:1.38
Open:1.38
Low:1.31
Close:1.38
Loading ...
Apr 14, 2025

Major Issues Report

Form 8-K - Current report
Mar 31, 2025

Major Issues Report

Form 8-K - Current report
Mar 28, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 24, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 06, 2025

Major Issues Report

Form 8-K - Current report
Feb 26, 2025

Major Issues Report

Form 8-K - Current report
Feb 03, 2025

Major Issues Report

Form 8-K - Current report
Jan 30, 2025

Correspondence

Form CORRESP - Correspondence
Jan 30, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 30, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 27, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jan 21, 2025

Major Issues Report

Form 8-K - Current report
Jan 14, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jan 03, 2025

Major Issues Report

Form 8-K - Current report
Nov 22, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 15, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report